-
Serum Institute seeks test licence from DCGI to manufacture Covid vaccine Sputnik V
Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories
-
Covid vaccine: Marginalised sections would bear brunt due to digital divide, says SC
The Supreme Court also noted that even the digitally literate are finding it hard to procure vaccination slots through CoWIN portal
-
SC directs govt to place on record documents, file notings on Covid vaccination policy
The top court also asked the Centre to specify the steps being taken by it to ensure drug availability for mucormycosis or black fungus
-
Over 1.64 crore Covid-19 vaccines still available with states: Centre
The Centre has so far provided, both through the free of cost and through direct state procurement categories, more than 23 crore vaccine doses to s
-
By July or early Aug, will have enough vaccine to inoculate 1 crore people a day: Centre
The Centre also said that mixing vaccines is not a protocol till further update and there is no change in the schedule of the two-dose Covishield and
-
Consignment of 3 million doses of Sputnik V vaccine from Russia land in Hyderabad
The Sputnik V vaccine requires specialised handling and storage, required to be kept at a temperature of -20 C.
-
Delhi likely to get Sputnik V in June: Arvind Kejriwal
Delhi CM Arvind Kejriwal also said the city currently has around 944 cases of mucormycosis or black fungus, including 300 at the central government-ru
-
Delhi International Airport launches dedicated Covid-19 vaccine centre
Set up at Terminal-1 of Indira Gandhi International Airport, the facility aims to provide vaccination opportunity to over 60,000 employees of various
-
Will be able to manufacture, supply 10 crore Covishield doses in June: Serum Institute to Centre
In early May, SII had communicated to the Centre that production of Covishield would be ramped up to 6.5 crore in June, seven crore in July and 10 cro
-
European regulators OK Pfizer vaccine for children 12-15
The European Union regulator had received the necessary data to authorise the vaccine for younger teens and found it to be highly effective against Co
